Abstract
Abstract
Deficiency in SWItch/Sucrose Non-FermenTable (SWI/SNF) related barrier-to-autointegration factor (BAF) chromatin remodeling complex subunit ATPase 4 (SMARCA4) drives aggressive behavior across various undifferentiated malignancies. However, its clinicopathological features, prognostic analysis, and molecular significance in undifferentiated digestive system malignancies, clinically rare and poorly characterized entities, remain incompletely elucidated. This study investigated the clinicopathological characteristics and prognostic significance of a retrospective cohort (n = 43). Immunohistochemistry (IHC) identified SMARCA4 deficiency in 30.2% of undifferentiated malignant tumors of the digestive system. Clinically, SMARCA4 deficiency constituted a significant poor-prognosis predictor, correlating with poorer overall survival [OS; hazard ratio (HR) = 3.054, 95% confidence interval (CI) 1.277-7.306, log-rank p = 0.006] and disease-free survival (DFS; HR = 2.717, 95% CI 1.129-6.539, log-rank p = 0.015), independent of assessed lineage markers or microsatellite status. Integrated analysis of The Cancer Genome Atlas (TCGA) data of digestive system malignancies revealed that SMARCA4-mutated tumors exhibited elevated tumor mutational burden (TMB) and distinct co-mutation patterns. Notably, SMARCA4 mutations significantly co-occurred with multiple potentially actionable therapeutic targets, including receptor tyrosine kinases (ERBB2, ERBB3, MET, and RET), DNA damage response genes (BRCA2), and mismatch repair genes (MLH1, MSH2, MSH6). Collectively, our findings identified SMARCA4 deficiency as a predictor of poor prognoses in digestive system malignancies, suggesting a distinct genomic context that may inform therapeutic stratification, including targeted and immunotherapeutic approaches, by focusing on these high-frequency co-mutated targets. © 2026 The Pathological Society of Great Britain and Ireland.
Direct answer
What can I do from this paper page?
Use this page to scan "SMARCA4 ‐deficient undifferentiated malignancies in the digestive system: clinicopathological features and prognostic significance with genomic insights from the TCGA cohort" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Chromatin Remodeling and Cancer research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Guo2026SMARCA4,
title = {SMARCA4 ‐deficient undifferentiated malignancies in the digestive system: clinicopathological features and prognostic significance with genomic insights from the TCGA cohort},
author = {Yun-Ran Guo and Chang Liu and Xiao Bai and Ke‐Chen Li and Jia‐Bao Zhao and Kun Lin and Zi-Ting Zhao and Ji‐Xuan Lang and Xiao‐Han Li and Qi‐Jun Wu and Chun‐Dong Zhang},
journal = {The Journal of Pathology},
year = {2026},
doi = {10.1002/path.70107},
url = {https://doi.org/10.1002/path.70107}
}
FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Chromatin Remodeling and Cancer research papers?
Follow Chromatin Remodeling and Cancer research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for SMARCA4 ‐deficient undifferentiated malignancies in the digestive system: clinicopathological features and prognostic significance with genomic insights from the TCGA cohort. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app